|
1
|
Slootweg PJ and Eveson JW: Tumours of the
oral cavity and oropharynx. World Health Organization
Classification of Tumours. Pathology & Genetics of Head and
Neck Tumours. Barnes L, Eveson JW, Reichart P and Sidransky D:
(Lyon). IARC Press. 166–167. 2005.
|
|
2
|
Genden EM, Ferlito A, Bradley PJ, Rinaldo
A and Scully C: Neck disease and distant metastases. Oral Oncol.
39:207–212. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaichi S, Hasegawa K, Takaya T, et al:
Cell line-dependent differentiation of induced pluripotent stem
cells into cardiomyocytes in mice. Cardiovasc Res. 88:314–323.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chambers I and Tomlinson SR: The
transcriptional foundation of pluripotency. Development.
136:2311–2322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Evans PM and Liu C: Roles of Krüppel-like
factor 4 in normal homeostasis cancer and stem cells. Acta Biochim
Biophys Sin (Shanghai). 40:554–564. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsu LS, Chan CP, Chen CJ, Lin SH, Lai MT,
Hsu JD, Yeh KT and Soon MS: Decreased Krüppel-like factor 4 (KLF4)
expression may correlate with poor survival in gastric
adenocarcinoma. Med Oncol. 30:6322013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patel NV, Ghaleb AM, Nandan MO and Yang
VW: Expression of the tumor suppressor Krüppel-like factor 4 as a
prognostic predictor for colon cancer. Cancer Epidemiol Biomarkers
Prev. 19:2631–2638. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Adhikary S and Eilers M: Transcriptional
regulation and transformation by Myc proteins. Nat Rev Mol Cell
Bio. 6:635–645. 2005. View
Article : Google Scholar
|
|
11
|
He W, Li K, Wang F, Qin YR and Fan QX:
Expression of OCT4 in human esophageal squamous cell carcinoma is
significantly associated with poorer prognosis. World J
Gastroenterol. 18:712–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Neumann J, Bahr F, Horst D, Kriegl L,
Engel J, Luque RM, Gerhard M, Kirchner T and Jung A: SOX2
expression correlates with lymph-node metastases and distant spread
in right-sided colon cancer. BMC Cancer. 11:5182011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ruan J, Wei B, Xu Z, Yang S, Zhou Y, Yu M,
Liang J, Jin K, Huang X, Lu P and Cheng H: Predictive value of SOX2
expression in transurethral resection specimens in patients with T1
bladder cancer. Med Oncol. 30:4452013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang X, Han B, Huang J, Zheng B, Geng Q,
Aziz F and Dong Q: Prognostic significance of OCT4 expression in
adenocarcinoma of the lung. Jpn J Clin Oncol. 40:961–966. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sholl LM, Barletta JA, Yeap BY, Chirieac
LR and Hornick JL: SOX2 protein expression is an independent poor
prognostic indicator in stage I lung adenocarcinoma. Am J Surg
Pathol. 34:1193–1198. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vidricaire G, Jardine K and McBurney MW:
Expression of the brachyury gene during mesoderm development in
differentiating embryonal carcinoma cell cultures. Development.
120:115–122. 1994.PubMed/NCBI
|
|
17
|
Kispert A, Herrmann BG, Leptin M and
Reuter R: Homologs of the mouse brachyury gene are involved in the
specification of posterior terminal structures in Drosophila,
Tribolium and Locusta. Genes Dev. 8:2137–2150. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishii K, Shimoda M, Sugiura T, Seki K,
Takahashi M, Abe M, Matsuki R, Inoue Y and Shirasuna K: Involvement
of epithelial-mesenchymal transition in adenoid cystic carcinoma
metastasis. Int J Oncol. 38:921–931. 2011.PubMed/NCBI
|
|
19
|
Shimoda M, Sugiura T, Imajyo I, Ishii K,
Chigita S, Seki K, Kobayashi Y and Shirasuna K: The T-box
transcription factor brachyury regulates epithelial-mesenchymal
transition in association with cancer stem-like cells in adenoid
cystic carcinoma cells. BMC Cancer. 12:3772012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kobayashi Y, Sugiura T, Imajyo I, Shimoda
M, Ishii K, Akimoto N, Yoshihama N and Mori Y: Knockdown of the
T-box transcription factor brachyury increases sensitivity of
adenoid cystic carcinoma cells to chemotherapy and radiation in
vitro, Implications for a new therapeutic principle. Int J Oncol.
44:1107–1117. 2014.PubMed/NCBI
|
|
21
|
Fernando RI, Litzinger M, Trono P,
Hamilton DH, Schlom J and Palena C: The T-box transcription factor
brachyury promotes epithelial-mesenchymal transition in human tumor
cells. J Clin Invest. 120:533–544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Imajyo I, Sugiura T, Kobayashi Y, Shimoda
M, Ishii K, Akimoto N, Yoshihama N, Kobayashi I and Mori Y: T-box
transcription factor brachyury expression is correlated with
epithelial-mesenchymal transition and lymph node metastasis in oral
squamous cell carcinoma. Int J Oncol. 41:1985–1995. 2012.PubMed/NCBI
|
|
23
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours (7th). Hoboken, NJ:
Wiley-Blackwell. 2009.
|
|
24
|
Pindborg JJ, Reichart PA, Smith CJ and van
der Waal I: World Health Organization International Histological
Classification of Tumours. Histological Typing of Cancer and
Precancer of the Oral Mucosa (Berlin). Springer-Verlag. 1997.
View Article : Google Scholar
|
|
25
|
Anneroth G, Hansen LS and Silverman S Jr:
Malignancy grading in oral squamous cell carcinoma. I. Squamous
cell carcinoma of the tongue and floor of mouth Histologic grading
in the clinical evaluation. J Oral Pathol. 15:162–168. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Anneroth G, Batsakis J and Luna M: Review
of the literature and a recommended system of malignancy grading in
oral squamous cell carcinomas. Scand J Dent Res. 95:229–249.
1987.PubMed/NCBI
|
|
27
|
Nomura A, Banerjee S, Chugh R, Dudeja V,
Yamamoto M, Vickers SM and Saluja AK: CD133 initiates tumors,
induces epithelial-mesenchymal transition and increases metastasis
in pancreatic cancer. Oncotarget. 6:8313–8322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
González-Moles MA, Scully C, Ruiz-Ávila I
and Plaza-Campillo JJ: The cancer stem cell hypothesis applied to
oral carcinoma. Oral Oncol. 49:738–746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu CC, Hu FW, Yu CH and Chou MY: Targeting
CD133 in the enhancement of chemosensitivity in oral squamous cell
carcinoma-derived side population cancer stem cells. Head Neck Dec.
24:2014.(Epub ahead of print).
|
|
30
|
Patel SS, Shah KA, Shah MJ, Kothari KC and
Rawal RM: Cancer stem cells and stemness markers in oral squamous
cell carcinomas. Asian Pac J Cancer Prev. 15:8549–8556. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu K, Lin B, Zhao M, Yang X, Chen M, Gao
A, Liu F, Que J and Lan X: The multiple roles for Sox2 in stem cell
maintenance and tumorigenesis. Cell Signal. 25:1264–1271. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L,
Liu Y, Reisfield RA, Xiang R, Xiang R, Lv D and Li N: SOX2 gene
regulates the transcriptional network of oncogenes and affects
tumorigenesis of human lung cancer cells. PLoS One. 7:e363262012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Forghanifard MM, Khales Ardalan S,
Javdani-Mallak A, Rad A, Farshchian M and Abbaszadegan MR: Stemness
state regulators SALL4 and SOX2 are involved in progression and
invasiveness of esophageal squamous cell carcinoma. Med Oncol.
31:9222014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lengerke C, Fehm T, Kurth R, Neubauer H,
Scheble V, Müller F, Schneider F, Petersen K, Wallwiener D, Kanz L,
et al: Expression of the embryonic stem cell marker SOX2 in
early-stage breast carcinoma. BMC Cancer. 11:422011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kitamura H, Torigoe T, Hirohashi Y,
Asanuma H, Inoue R, Nishida S, Tanaka T, Fukuta F, Masumori N, Sato
N and Tsukamoto T: Prognostic impact of the expression of ALDH1 and
SOX2 in urothelial cancer of the upper urinary tract. Mod Pathol.
26:117–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boumahdi S, Driessens G, Lapouge G, Rorive
S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E,
et al: SOX2 controls tumour initiation and cancer stem-cell
functions in squamous-cell carcinoma. Nature. 511:246–250. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Episkopou V: SOX2 functions in adult
neural stem cells. Trends Neurosci. 28:219–221. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tai SK, Yang MH, Chang SY, Chang YC, Li
WY, Tsai TL, Wang YF, Chu PY and Hsieh SL: Persistent Krüppel-like
factor 4 expression predicts progression and poor prognosis of head
and neck squamous cell carcinoma. Cancer Sci. 102:895–902. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pandya AY, Talley LI, Frost AR, Fitzgerald
TJ, Trivedi V, Chakravarthy M, Chhieng DC, Grizzle WE, Engler JA,
Krontiras H, et al: Nuclear localization of KLF4 is associated with
an aggressive phenotype in early-stage breast cancer. Clin Cancer
Res. 10:2709–2719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen BJ, Wu YL, Tanaka Y and Zhang W:
Small molecules targeting c-Myc oncogene, Promising anti-cancer
therapeutics. Int J Biol Sci. 10:1084–1096. 2014. View Article : Google Scholar : PubMed/NCBI
|
